🩺 Comprehensive Hepatology & Liver Transplant Services – Dr. Chetan R. Kalal
India’s Leading Hepatologist & Liver Transplant Specialist
Maharashtra’s First DM Hepatologist | Expert in IPD & ICU Care, ALF/ACLF, Obesity & MASLD | Virtual Consultations Worldwide
🔹 Why This Update Matters
Liver disease is now among the top 10 causes of death in India. From acute liver failure (ALF) to acute-on-chronic liver failure (ACLF) and advanced cirrhosis, timely expert care saves lives. As Maharashtra’s first DM Hepatologist, Dr. Chetan Kalal leads the way in ICU stabilization, transplant coordination, and global virtual second opinions.
🏥 In-Patient (IPD) & ICU Liver Services
Dr. Kalal provides comprehensive inpatient and ICU-based hepatology care across Mumbai:
Acute Liver Failure (ALF): Early recognition, ICU stabilization, bridging therapies (plasma exchange, MARS/HVPE).
Acute-on-Chronic Liver Failure (ACLF): Aggressive sepsis control, organ support, transplant readiness.
ICU hepatology consults: Advanced liver support, nutrition, infection management, multi-organ coordination.
Pre-transplant optimization: MELD scoring, fitness evaluation, urgent listing.
Critical rescue therapies: HVPE, TPE, renal replacement therapy, endoscopic bleeding control.
🔹 Liver Transplantation – Full Spectrum Care
Evaluation: MELD & Child-Pugh based transplant candidacy.
Surgery Pathways: Living donor and deceased donor options with ethical donor selection.
Post-transplant care: Immunosuppression tailoring (Tacrolimus + mTOR strategies), rejection monitoring, infection prevention.
Chronic rejection protocols: Evidence-based management (biopsy, DSA/C4d, everolimus strategies, rescue therapy, retransplant criteria).
🔹 Expert Second Opinions – Local & International
Detailed case reviews for patients advised transplant or with complex liver disease.
International patients (US, UK, UAE, Dubai, London, Singapore, Canada, Europe, New Zealand, Australia, Middle East, Asia, Africa, Paris) can book structured virtual consults for guidance before traveling.
Independent expert reports to guide patients and families on the best path forward.
🔹 Obesity, MASLD & Metabolic Liver Health
GLP-1 & GIP agonists (Semaglutide, Tirzepatide): Effective for obesity + fatty liver reversal.
Resmetirom: New NASH-targeted therapy showing fibrosis reduction.
Integrated obesity clinic model: Hepatology + endocrinology + nutrition + lifestyle medicine.
Monitoring: FibroScan, MRI-PDFF, and non-invasive fibrosis scoring.
📍 Patient Access in Mumbai
Dr. Kalal provides services in South Mumbai, Worli, Lower Parel, Bandra (Pali Hill), Khar, Andheri, Kandivali, Lokhandwala, Versova, Navi Mumbai, Dadar, Juhu, Vile Parle.
🌐 Virtual Consults Worldwide
Patients across US, UK, UAE/Dubai, London, Canada, Singapore, Europe, Asia, Australia, New Zealand, Middle East, Paris, and Africa can access Dr. Kalal’s expertise through virtual second opinions and follow-up care.
✅ Why Patients Trust Dr. Chetan Kalal
First DM Hepatologist of Maharashtra
Celebrity hepatologist, trusted by public figures & international patients
Known for life-saving ICU interventions in ALF/ACLF
Authority in liver transplant, second opinions, and obesity-driven fatty liver
Global reputation for precision, empathy, and outcomes
📞 Book Your Consultation
If you or a loved one has acute liver failure, ACLF, advanced cirrhosis, fatty liver, or has been advised a transplant, get an expert, evidence-based opinion.
👉 Visit drchetankalal.com to book an IPD evaluation, ICU consult, or virtual second opinion today.